CJC-1295 (with DAC)

What it is

CJC-1295 with DAC carries a maleimidopropionic-acid linker that binds the peptide to serum albumin after administration in research models, extending its half-life to days rather than minutes. It is otherwise the same tetra-substituted GHRH(1-29) analogue.

Where it has been studied

Literature search: PubMed, "CJC-1295 DAC albumin". The areas listed describe published research, not outcomes.

• Sustained GHRH receptor activation models
• Growth hormone and IGF-1 axis studies
• Albumin-binding peptide pharmacokinetics